113 related articles for article (PubMed ID: 28639202)
1. Suppression of Prostate Cancer Metastasis by DPYSL3-Targeted saRNA.
Li B; Li C
Adv Exp Med Biol; 2017; 983():207-216. PubMed ID: 28639202
[TBL] [Abstract][Full Text] [Related]
2. Enhancing DPYSL3 gene expression via a promoter-targeted small activating RNA approach suppresses cancer cell motility and metastasis.
Li C; Jiang W; Hu Q; Li LC; Dong L; Chen R; Zhang Y; Tang Y; Thrasher JB; Liu CB; Li B
Oncotarget; 2016 Apr; 7(16):22893-910. PubMed ID: 27014974
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of CRMP4, a new prostate cancer metastasis suppressor gene, inhibits tumor growth in a nude mouse intratibial injection model.
Zhou W; Xie P; Pang M; Yang B; Fang Y; Shu T; Liu C; Wang X; Zhang L; Li S; Rong L
Int J Oncol; 2015 Jan; 46(1):290-8. PubMed ID: 25338524
[TBL] [Abstract][Full Text] [Related]
4. Targeted induction of endogenous NKX3-1 by small activating RNA inhibits prostate tumor growth.
Ren S; Kang MR; Wang J; Huang V; Place RF; Sun Y; Li LC
Prostate; 2013 Oct; 73(14):1591-601. PubMed ID: 23836514
[TBL] [Abstract][Full Text] [Related]
5. Development of Therapeutic dsP21-322 for Cancer Treatment.
Kang MR; Li G; Pan T; Xing JC; Li LC
Adv Exp Med Biol; 2017; 983():217-229. PubMed ID: 28639203
[TBL] [Abstract][Full Text] [Related]
6. Manipulation of prostate cancer metastasis by locus-specific modification of the CRMP4 promoter region using chimeric TALE DNA methyltransferase and demethylase.
Li K; Pang J; Cheng H; Liu WP; Di JM; Xiao HJ; Luo Y; Zhang H; Huang WT; Chen MK; Li LY; Shao CK; Feng YH; Gao X
Oncotarget; 2015 Apr; 6(12):10030-44. PubMed ID: 25888628
[TBL] [Abstract][Full Text] [Related]
7. Calpain-2 triggers prostate cancer metastasis via enhancing CRMP4 promoter methylation through NF-κB/DNMT1 signaling pathway.
Gao X; Mao YH; Xiao C; Li K; Liu W; Li LY; Pang J
Prostate; 2018 Jun; 78(9):682-690. PubMed ID: 29601651
[TBL] [Abstract][Full Text] [Related]
8. Expression profiling identifies new function of collapsin response mediator protein 4 as a metastasis-suppressor in prostate cancer.
Gao X; Pang J; Li LY; Liu WP; Di JM; Sun QP; Fang YQ; Liu XP; Pu XY; He D; Li MT; Su ZL; Li BY
Oncogene; 2010 Aug; 29(32):4555-66. PubMed ID: 20543870
[TBL] [Abstract][Full Text] [Related]
9. C/EBPα Short-Activating RNA Suppresses Metastasis of Hepatocellular Carcinoma through Inhibiting EGFR/β-Catenin Signaling Mediated EMT.
Huan H; Wen X; Chen X; Wu L; Liu W; Habib NA; Bie P; Xia F
PLoS One; 2016; 11(4):e0153117. PubMed ID: 27050434
[TBL] [Abstract][Full Text] [Related]
10. Small activating RNA binds to the genomic target site in a seed-region-dependent manner.
Meng X; Jiang Q; Chang N; Wang X; Liu C; Xiong J; Cao H; Liang Z
Nucleic Acids Res; 2016 Mar; 44(5):2274-82. PubMed ID: 26873922
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of VEZT by small activating RNA inhibits the proliferation, invasion and migration of gastric cancer cells.
Xie D; Shang L; Peng L; Li L
Biochem Biophys Res Commun; 2017 Jan; 482(4):542-548. PubMed ID: 27856244
[TBL] [Abstract][Full Text] [Related]
12. Ovarian cancer G protein-coupled receptor 1, a new metastasis suppressor gene in prostate cancer.
Singh LS; Berk M; Oates R; Zhao Z; Tan H; Jiang Y; Zhou A; Kirmani K; Steinmetz R; Lindner D; Xu Y
J Natl Cancer Inst; 2007 Sep; 99(17):1313-27. PubMed ID: 17728215
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cell-adhesion protein DPYSL3 promotes metastasis of lung cancer.
Yang Y; Jiang Y; Xie D; Liu M; Song N; Zhu J; Fan J; Zhu C
Respir Res; 2018 Mar; 19(1):41. PubMed ID: 29514686
[TBL] [Abstract][Full Text] [Related]
14. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
[TBL] [Abstract][Full Text] [Related]
15. Targeted p53 activation by saRNA suppresses human bladder cancer cells growth and metastasis.
Wang C; Ge Q; Zhang Q; Chen Z; Hu J; Li F; Ye Z
J Exp Clin Cancer Res; 2016 Mar; 35():53. PubMed ID: 27012825
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of PAWR by small activating RNAs induces cell apoptosis in human prostate cancer cells.
Yang K; Shen J; Chen SW; Qin J; Zheng XY; Xie LP
Oncol Rep; 2016 Apr; 35(4):2487-93. PubMed ID: 26797252
[TBL] [Abstract][Full Text] [Related]
17. An EP4 antagonist ONO-AE3-208 suppresses cell invasion, migration, and metastasis of prostate cancer.
Xu S; Zhang Z; Ogawa O; Yoshikawa T; Sakamoto H; Shibasaki N; Goto T; Wang L; Terada N
Cell Biochem Biophys; 2014 Sep; 70(1):521-7. PubMed ID: 24744183
[TBL] [Abstract][Full Text] [Related]
18. Specific up-regulation of p21 by a small active RNA sequence suppresses human colorectal cancer growth.
Wang LL; Guo HH; Zhan Y; Feng CL; Huang S; Han YX; Zheng WS; Jiang JD
Oncotarget; 2017 Apr; 8(15):25055-25065. PubMed ID: 28445988
[TBL] [Abstract][Full Text] [Related]
19. Reduced c-Met expression by an adenovirus expressing a c-Met ribozyme inhibits tumorigenic growth and lymph node metastases of PC3-LN4 prostate tumor cells in an orthotopic nude mouse model.
Kim SJ; Johnson M; Koterba K; Herynk MH; Uehara H; Gallick GE
Clin Cancer Res; 2003 Nov; 9(14):5161-70. PubMed ID: 14613995
[TBL] [Abstract][Full Text] [Related]
20. Collapsin response mediator protein 4 expression is associated with liver metastasis and poor survival in pancreatic cancer.
Hiroshima Y; Nakamura F; Miyamoto H; Mori R; Taniguchi K; Matsuyama R; Akiyama H; Tanaka K; Ichikawa Y; Kato S; Kobayashi N; Kubota K; Nagashima Y; Goshima Y; Endo I
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S369-78. PubMed ID: 22805864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
